View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 09/09: (EXPE) (BRCD) (MU) Upgraded; (FITB) (PSX) (MPC) Downgraded
-
Lazard Capital Upgrades Expedia (EXPE) to Buy
-
Lazard Capital Upgrades Moody's Corp (MCO) to Buy
-
Notable Analyst Rating Changes 09/05: (GRPN) (RIG) (OMC) Upgraded; (BBRY) (Z) (LMT) Downgraded
-
MacroGenics (MGNX) Files $60M IPO
-
Lazard Capital Upgrades Omnicom Group (OMC) to Buy
-
Unusual 11 Mid-Day Movers 09/04: (ROCM) (FFHL) (LIVE) Higher; (FRAN) (UNIS) (RYAAY) Lower
-
Notable Analyst Rating Changes 09/04: (MET) (NSU) (CBS) Upgraded; (MSFT) (VVUS) (ARCP) Downgraded
-
Lazard Capital Upgrades Pharmacyclics (PCYC) to Buy
-
Lazard Capital Downgrades Vivus (VVUS) to Sell
-
Lazard Capital Downgrades ArQule (ARQL) to Neutral
-
Notable Analyst Rating Changes 08/29: (INFY) (ETR) (MHK) Upgraded; (ABB) (AMAP) (LTXC) Downgraded
-
Pre-Open Stock Movers 8/29: (MEI) (GES) (VOD) Higher; (COCO) (SIG) (TFM) Lower (more...)
-
Lazard Capital Starts ImmunoCellular Therapeutics (IMUC) at Buy
-
Notable Mergers and Acquisitions of the Day 08/26: (AMGN)/(ONXX) (APC) (GCOM) (TMS)
-
Amgen (AMGN) to Acquire Onyx Pharma (ONXX) for $125/Share
-
Lazard Keeps Teradata (TDC) at Buy; Checks Indicate Strong H213 Performance
-
Notable Analyst Rating Changes 08/20: (ONXX) (WY) (ANN) Upgraded; (RVBD) (GTXI) (XEL) Downgraded
-
Lazard Capital Downgrades GTX Inc. (GTXI) to Neutral
-
Market Wrap: China's Housing Prices Bolster Gains; GTX Loses POWER, Market Cap; Shire Plays 'D'
-
Shire (SHPG) Taps Lazard for M&A Defense
-
Edwards Group (EVAC) Acquired for Up to $10.50/Sh by Atlas Copco Group
-
Notable 52-Week Highs and Lows of the Day 08/15: (NVAX) (A) (TASR) High; (TXCC) (MACK) (EQIX) Low
-
Novavax (NVAX) Pops as Lazard Lauds RSV Vaccine, Nearly Triples PT to $11
-
Lazard as Cautious as Management on Cisco (CSCO) Following Q4 Results, Outlook
-
Peltz Trian Fund Shows New Stake in DuPont (DD), GNC (GNC), (more...)
-
Lazard Keeps Brocade (BRCD) at Neutral; Q3 Results Strong, Would Like More 'Strategic Vision' Clarity
-
Notable Analyst Rating Changes 08/13: (XRX) (MRVL) (AMRN) Upgraded; (MSFT) (UPL) (FITB) Downgraded
-
Lazard Firm on NetApp (NTAP) Into Q1 Report; Still Sees EMC (EMC) as Better Play
-
Lazard Capital Upgrades Constant Contact (CTCT) to Buy
-
Shorts Aren't Giving Up on Tesla (TSLA) Quite Yet
-
Notable Analyst Rating Changes 08/12: (FFIV) (CVC) (LKQ) Upgraded; (TSLA) (VOYA) (JNPR) Downgraded
-
Notable Mergers and Acquisitions of the Day 08/12: (BBRY) (DOLE) (COL) (LVB) (PF)/(UL)
-
Pre-Open Stock Movers 8/12: (LDK) (LVB) (BBRY) Higher; (VICL) (ISIS) (TSLA) Lower (more...)
-
Dole Food (DOLE) CEO Murdock to Acquire Co. for $13.50/Sh
-
Tesla (TSLA) Will Be Next Big Bubble to Burst
-
Bull and Bears Lock Horns in Tesla (TSLA) Monday
-
UPDATE: Tesla (TSLA) Cut to Neutral at Lazard; Any Execution Issue May Send Stock to $100
-
Lazard Keeps Emulex (ELX) at Neutral; No Surprise in Q4 Results, No Improvement Expected Yet
-
Lazard Capital Downgrades Orbitz Worldwide Inc. (OWW) to Neutral
-
Streetinsider.com's Hot Lunchtime Reads 08/08: (JCP) (FDO) (MSFT) (CAT)
-
Lazard Cuts PT on Fusion-io (FIO) to $17; Company Now in 4th and Long Scenario
-
Lazard Still Neutral on Cisco (CSCO) Heading Into FQ4 Report; Sees Conservative Outlook
-
Streetinsider.com's Hot Lunchtime Reads 08/07: (GLUU) (USU) (TSLA) (ARUN) (GOOG)
-
Lazard Boosts PT on Aruba (ARUN) Into Q4 Results; Checks Indicate Potential Upside to Ests
-
Vanda Pharma (VNDA) Prices 4.68M Offering at $11.14/Share
-
Organovo Holdings (ONVO) Prices 9M Common Stock Offering
-
Lazard Boosts PT on Teradata (TDC) to $75; Q2 Results Solid, Weakness Not Co. Specific
-
Streetinsider.com's Hot Lunchtime Reads 08/01: (JCP) (AAPL) (APOL) (FCX) (RKUS)
-
Lazard Keeps Ruckus (RKUS) at Neutral Following Q2 Report; Caution Around SP Evident in Outlook

